Aim: To implement the HPV genotyping method of fresh head and neck cancer samples in our laboratory.
More than half of the patients recognized being chronic alcohol and tobacco users. Conclusions: The genotyping method was validated according to kit instructions. To get a general idea on the prevalence of HPV genotypes in head and neck cancer in our region we tested a very small number of samples.
Ferlay J, Soerjomataram I et al. Comprehensive control of human papillomavirus infections and related diseases. Venuti A, Paolini F.
All patients were males, years old, in different TNM stages.
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Ursu RG, Danciu M et al.
Virol J. Human papillomavirus prevalence in invasive laryngeal cancer in the United States.
Shanesmith R, Allen RA et al. Comparison of 2 line blot assays oxiuri viermi intestinali defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas.
HUMAN PAPILLOMA VIRUS GENOTYPING IN FRESH HEAD AND NECK TUMORS - OUR FIRST EXPERIENCE
HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Garnaes E, Kiss K et al.
A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, the largest registry-based study to date. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.
Westra WH. Heiduschka G, Grah A et al.
- Ursu Ramona Gabriela, MD, PhD, Associate Professor - Google 学术搜索引用
- Tratamentul carcinoamelor de planşeu oral anterior
- Frequently, a mandible resection is required in order to obtain safe oncologic margins.
- Comentarii Thieme congratulates Dr.
Masterson L, Moualed D et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systema-tic review and meta-analysis of current clinical trials.